AGR2 Antikörper (N-Term)
Kurzübersicht für AGR2 Antikörper (N-Term) (ABIN3023708)
Target
Alle AGR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A recombinant protein fragment from the N-terminal region of human AGR2 was used as the immunogen for this antibody.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Provided assay concentrations are suggestions only, AGR2 antibody titration may be required for optimal results.\. Western blot: 4-8 μg/mL,IHC (FFPE): 3-5 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.5 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the AGR2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- AGR2 (Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2))
-
Andere Bezeichnung
- AGR2
-
Hintergrund
- AGR2 (Anterior gradient protein 2 homolog) is thought to promote breast tumorigenesis and is overexpressed in breast cancer cells. High levels of AGR2 indicate a poor prognosis. This suggests it may serve as a useful prognostic indicator and marker of breast cancer metastasis.
-
Gen-ID
- 10551
Target
-